Overview

Figure 1: Overview of our technology

Our product is a sensor for a variety of oil and gas related contaminants in water. The system is rapid and portable, allowing for monitoring of toxins much more quickly and easily than present systems allow. Our sensor utiliizes a strain of soil bacteria which has been synthetically designed to react to toxins in the environment by producing enzymes capable of changing compounds so that they can be detected electrochemically. Detection of electroactive chemicals is quantitative and and software analysis of the results permits the user to measure the amount of toxin using a simple computer, USB, WiFi, or GPS based interface.

Presently we have shown our strain to be able to detect three relevant oil sands toxins (naphthenic acids, carbazole, and dibenzothiophene) and that it does not react to other stresses such as hydrogen peroxide or healthy compounds (decanoic acid). We have demonstrated that we can measure the production of our electrochemical analytes and working to demonstrate that we can use multiple enzyme/electroactive compounds simultaneously to make our system more effective. Therefore, we have a proof-of-concept technology which will require further refinement prior to developing a prototype system.

Technical Description of the Technology

Sensing Microorganism:

A transposon screen using an electrochemical reporting enzyme (lacZ) was performed on Pseudomonas fluorescens Pf-5 (a native tailings pond organism shown to degrade oil sands toxins), and strains were found which respond to general oil sands toxins (sulfur-heterocycles, nitrogen heterocycles, and naphthenic acids were specifically shown to elicit a response higher than baseline, without responding to general hydrocarbon compounds and stress agents). This response consisted of production of a reporter enzyme capable of cleaving a substrate which could then give an electrochemical response. Further testing on one strain using actual tailings pond samples showed a higher than baseline response, and the organism was capable of survival in the toxic substrate. The sensing elements themselves have not been identified or characterized as of yet, and the system has yet to be multiplexed, providing only one output for general toxin response.

Figure 2 - Toxin Sensing Strain detects pure toxin samples. X-Gal blue-white screening assay. Cells were inoculated in duplicate at different dilutions into LB as a control, and LB containing different toxin compounds at environmental concentrations. Absorbance was read at 615nm (maximal absorbance of X-gal) every hour.

Figure 3 - Toxin Sensing Strain detects toxins in environmental tailing pond samples. Current change over time illustrating lacZ induction by our identified transposon sensory element in a tailings pond water sample. Phosphate Buffer Saline (PBS) was used as a base-line negative control.

Electrochemical Enzymatic Reporting System:

The oxidation potential chlorophenol red (CPR), para-diphenol (PDP), and para-nitrophenol (PNP) as substrates was tested. These compounds are conjugated with their sugars to form CPR-β-D-galactopyranoside (CPRG), PDP-β-D-glucopyranoside (PDPG), and PNP-β-D-glucuronide (PNPG). It was found that when measured using cyclic voltammetry, the oxidation potentials of the three substrates were distinct and could be visualised separately on the resulting graph, showing the potential for multiplexing the system.

Three hydrolase enzymes were identified which have been shown to act on these substrates; beta-D-glucoside glucohydrolase (bglX gene), beta-glucuronidase (uidA gene), and beta-galactosidase (lacZ gene). Commercial versions of these enzymes were tested and it was shown that by cleaving their substrates an electrochemical signal could be detected by a potentiostat. These enzymes were put into standardized plasmid backbones for expression in Escherichia coli under control of an inducible promoter for testing.

Figure 4 - Enzymatic production of electro-active compounds in live cells. A) Detection of lacZ activity on CPRG at 1.325V vs RHE through the production of CPR. B) Cleavage of PDPG into PDP by bglX being detected at 0.825V vs RHE. C) The action of uidA on PNPG at 1.6V vs RHE under an inducible plasmid system when IPTG is added (induced) or uninduced (leaky).

Hardware, Software, and Prototype Design:

A kinetic model was built for UidA in MatLab, predicting that a response could be detected within 4 minutes of adding the substrate to the enzyme when read electrochemically. This experiment was then performed in the wetlab by inducing UidA expression, and results were consistent with the models prediction.

Figure 5 - Model prediction and experimental results correlate for the production of the electroactive compound PNP. Experimental and modelling results for the uidA gene to cause cleavage of PNPG into PNP. Both results show that a detectable level of PNP is reached in under 4 minutes.

As well, an inexpensive, small, and portable potentiostat was designed and developed, with required circuitry being printed onto a small circuit board. While larger versions of the potentiostat were shown to function well, an error in the design of the circuit board renders the latest prototype nonfunctional at the moment, preventing further testing and refinement from being done. A custom software package within the MatLab platform was also developed in order to interpret and display the data obtained from electrochemical measurement.

Finally, a prototype device was designed, consisting of a small can-sized container where circuitry would be housed, a slot where a cartridge could be inserted into the housing, and a cartridge where the electrodes, analytes, and microorganisms could be housed with a lid allowing sample injection. The device contained LED lights in order to indicate what step of the reading was currently running as well as to indicate when analysis was finished.

Figure 6 - Cartridge system (left and middle) and early prototype device (middle and right).

Technical Implementation Plan

In order to realize our first generation product, there are several key steps that need to be taken on the research and development front. As such, we have created a detailed Implementation plan describing these necessary milestones. A condensed version can be seen below. Here we list the major technical milestones that need to be completed. These points are listed in order of priority with the earliest described experiments being most critical in evaluating the commercial potential of our technology. As such, the order represents the relative risk of each experiment, with the most high-risk experiments first, where failure to achieve good results could significantly impact the time and cost estimates for the research and development.

• Further multiplexing of our electrochemical system.
• Transferring our electrochemical system into P. fluorescencs.
• Completion of cloning the final system into our first generation product.
• Final characterization of first generation product.
• Transitioning our first product into the final prototyping stages.
• Optimization of the sample preparation protocol for the end user.
• Further screening for future generation products.

Responding to Technological Change

The current technology has been carefully designed in order to easily facilitate the production of next generation products. FREDsense’s unique sensing platform is easily adaptable to monitor a plethora of different compounds of interest using different engineered bacterial strains. Second generation products are being developed including detector products specific to unique classes of chemicals including naphthenic acids and hydrocarbons. As these are specific compounds of interest for many oil sands-related processes, detectors capable of monitoring them with specificity are sought-after. These detectors will make use of FREDsense’s novel generation one sensing platform coupled with newly developed bacterial strains. Being able to directly build upon the existing platform will help ensure FREDsense’s new products can be designed quickly and efficiently so as to have a quicker entry to market than generation one products.

With the introduction of more specific and diverse sensors, this will lead the way for multiple-output detector systems. These will include detectors that can monitor multiple different classes of compounds such as combinations of naphthenic acids, hydrocarbons and general toxins simultaneously. As many locations would require monitoring of a variety of compounds of interest at one sampling time, these second generation sensors will allow one water sample to be taken in order to monitor that sample for several toxins. This will allow for quicker sample extraction and faster results. Again, these products will make use of the generation one electrochemical sensing platform with new engineered bacterial strains.

As with generation one, all later generation products will include integrated controls as well as the speed and reliability of the generation one sensing platform. The modular design of FREDsense’s technology will allow the company to adapt quickly and easily to changes in the regulatory landscape in the oil sands market as well as expand into different markets. This will allow FREDsense to expand the breadth of its detection products without investing significant resources into research and development.

Regulatory Hurdles

Biotechnology products in Canada are regulated by three federal agencies: Health Canada for foods, Canadian Food Inspection Agency (CFIA) for seeds and livestock feed, and Environment Canada for new substances intended for environmental release. Our product thus falls under regulation set out by the later. This regulation falls under the Canadian Environmental Protection Act (jointly administered by Environment Canada and Health Canada). Environmental Technology Verification is also required for our technology to be used in this industry. Risk is assessed based on relative toxicity as well as relative amount of exposure to the environment. Specific products are assessed on a one-to-one basis through a dialogue with Environment Canada and Health Canada.